Annual Accounts Receivable
$16.12 M
+$8.93 M+124.34%
December 31, 2023
Summary
- As of February 7, 2025, ZVRA annual accounts receivable is $16.12 million, with the most recent change of +$8.93 million (+124.34%) on December 31, 2023.
- During the last 3 years, ZVRA annual accounts receivable has risen by +$13.68 million (+560.07%).
- ZVRA annual accounts receivable is now at all-time high.
Performance
ZVRA Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$7.79 M
-$1.16 M-12.93%
September 30, 2024
Summary
- As of February 7, 2025, ZVRA quarterly accounts receivable is $7.79 million, with the most recent change of -$1.16 million (-12.93%) on September 30, 2024.
- Over the past year, ZVRA quarterly accounts receivable has dropped by -$8.33 million (-51.67%).
- ZVRA quarterly accounts receivable is now -51.67% below its all-time high of $16.12 million, reached on December 31, 2023.
Performance
ZVRA Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ZVRA Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +124.3% | -51.7% |
| 3 y3 years | +560.1% | -51.7% |
| 5 y5 years | +100.0% | -51.7% |
ZVRA Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1034.3% | -51.7% | +448.2% |
| 5 y | 5-year | at high | +1034.3% | -51.7% | +448.2% |
| alltime | all time | at high | -100.0% | -51.7% | -100.0% |
Zevra Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.79 M(-12.9%) |
| Jun 2024 | - | $8.95 M(+7.7%) |
| Mar 2024 | - | $8.30 M(-48.5%) |
| Dec 2023 | $16.12 M(+124.3%) | $16.12 M(+62.4%) |
| Sep 2023 | - | $9.93 M(-14.4%) |
| Jun 2023 | - | $11.60 M(+48.3%) |
| Mar 2023 | - | $7.82 M(+8.9%) |
| Dec 2022 | $7.18 M(+405.6%) | $7.18 M(+9.1%) |
| Sep 2022 | - | $6.58 M(+133.4%) |
| Jun 2022 | - | $2.82 M(-15.1%) |
| Mar 2022 | - | $3.32 M(+133.6%) |
| Dec 2021 | $1.42 M | - |
| Dec 2021 | - | $1.42 M(-12.2%) |
| Sep 2021 | - | $1.62 M(-14.2%) |
| Jun 2021 | - | $1.89 M(-83.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $11.31 M(+363.1%) |
| Dec 2020 | $2.44 M(+45.3%) | $2.44 M(+10.9%) |
| Sep 2020 | - | $2.20 M(+5.2%) |
| Jun 2020 | - | $2.09 M(-7.6%) |
| Mar 2020 | - | $2.27 M(+34.7%) |
| Dec 2019 | $1.68 M(>+9900.0%) | $1.68 M(+2.6%) |
| Sep 2019 | - | $1.64 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(-100.0%) |
| Mar 2018 | - | $1.51 M(-24.6%) |
| Dec 2017 | $2.00 M(-59.9%) | $2.00 M(-19.9%) |
| Sep 2017 | - | $2.50 M(>+9900.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(-100.0%) |
| Dec 2016 | $5.00 M(>+9900.0%) | $5.00 M(>+9900.0%) |
| Dec 2015 | $0.00 | $0.00 |
FAQ
- What is Zevra Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Zevra Therapeutics?
- What is Zevra Therapeutics annual accounts receivable year-on-year change?
- What is Zevra Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly accounts receivable year-on-year change?
What is Zevra Therapeutics annual accounts receivable?
The current annual accounts receivable of ZVRA is $16.12 M
What is the all time high annual accounts receivable for Zevra Therapeutics?
Zevra Therapeutics all-time high annual accounts receivable is $16.12 M
What is Zevra Therapeutics annual accounts receivable year-on-year change?
Over the past year, ZVRA annual accounts receivable has changed by +$8.93 M (+124.34%)
What is Zevra Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of ZVRA is $7.79 M
What is the all time high quarterly accounts receivable for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly accounts receivable is $16.12 M
What is Zevra Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, ZVRA quarterly accounts receivable has changed by -$8.33 M (-51.67%)